One of the most important pieces of Australia’s medical cannabis puzzle—distribution—may finally be falling into place.

Cann Group charted a new high on news that it secured an import/export license for cannabis products, while penny stock The Hydroponics Company was also up.

The funds will be used to establish the Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), to coordinate cannabis research.

If the Canadian company PUF gets its way, Richmond Valley could soon become the home of the largest cannabis cultivation operation in the Southern Hemisphere.

Zelda Therapeutics announced it has completed an observation trial that found positive results when treating core symptoms of autism with cannabis extracts.

Senator Richard di Natale, leader of the Australian Greens party, has introduced a new bill which he hopes will fix two impediments in the Australian medical marijuana bill.

Blockchain, the technology that powers digital currencies like Bitcoin, will make a cannabis-sector debut in Australia with the help of Canadian cannabis app developer Global Cannabis.

Hundreds of Australian health-care workers have signed an open letter to the federal government asking officials not to implement mandatory drug testing for welfare recipients.

A report in the British Medical Journal found that baby boomers in the UK and Australia had greater increases in consumption than younger age groups.

As states take an array of approaches to regulating medical cannabis, some are calling for more consistency from the federal government.